Home › Funds › Empyrean Capital Partners, LP › ANIP

Empyrean Capital Partners, LP position in ANIP

ANI PHARMACEUTICALS INC COM · Health Care

Empyrean Capital Partners, LP reported holding 23,000,000 shares of ANIP (ANI PHARMACEUTICALS INC COM) in its Q2 2026 13F filing — a position valued at US$29.7M, representing 0.98% of its reported portfolio and ranking #32 among its reported holdings. Empyrean Capital Partners, LP has disclosed ANIP holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)23.00M sh
Reported value held$29.75M
Portfolio Weight0.98%
First reportedQ3 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Empyrean Capital Partners, LP's ANIP position evolved

Empyrean Capital Partners, LP first disclosed a stake in ANIP in Q3 2025 at 23,000,000 shares (US$32.3M). Across 4 filings, Empyrean Capital Partners, LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 23,000,000 shares valued at US$29.7M — a reduction of -500,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2025 23.00M $32.30M New
Q4 2025 21.00M $26.49M Reduce
Q1 2026 23.50M $29.09M Add
Q2 2026 23.00M $29.75M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANIP and 13F data

ANIP (ANI PHARMACEUTICALS INC COM) is a Health Care company. 48 other funds we track also report a position in ANIP — the largest reported positions include Soleus Capital Management, L.P. (US$71.8M), TANG CAPITAL MANAGEMENT LLC (US$58.6M), Global Alpha Capital Management Ltd. (US$46.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANIP

All ANIP fund holders →

FAQ

How long has Empyrean Capital Partners, LP held ANIP?

Empyrean Capital Partners, LP has disclosed ANIP holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Empyrean Capital Partners, LP's current position in ANIP?

As of Q2 2026, Empyrean Capital Partners, LP holds 23.00M shares of ANIP (ANI PHARMACEUTICALS INC COM), valued at $29.75M, representing 0.98% of its reported portfolio and ranking #32.

Has Empyrean Capital Partners, LP been buying or selling ANIP?

In the latest 13F filing (Q2 2026), Empyrean Capital Partners, LP reduced its position in ANIP.

Which other funds hold ANIP?

Other major institutional holders of ANIP include Soleus Capital Management, L.P., TANG CAPITAL MANAGEMENT LLC, Global Alpha Capital Management Ltd., among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.